Biomolecule-Polymer Conjugates for Extended Circulating Half-Life
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Biomolecules such as therapeutic proteins and oligonucleotides face limitations including poor stability, low solubility, and short circulating half-lives, leading to frequent administration and increased risk of adverse reactions.
Innovation Solution
Formation of biomolecule-polymer conjugates by attaching polymers in situ to the biomolecules, specifically at the N-terminus or C-terminus of polypeptides or 5′/3′ ends of polynucleotides, using methods like atom transfer radical polymerization (ATRP) or reversible addition-fragmentation chain transfer (RAFT) polymerization, to enhance stability and half-life.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stability of the object's composition
If biomolecules are administered in their unmodified forms, then they maintain high biological activity and specificity, but they exhibit poor stability, low solubility, and short circulating half-lives
Solution Approach 1:
The patent applies composite materials by conjugating biomolecules (proteins, oligonucleotides) with synthetic or natural polymers to create hybrid structures. This combination allows the biomolecule to retain its biological activity while the polymer component provides enhanced stability, solubility, and extended circulation half-life. The composite structure integrates the functional advantages of both biomolecular and polymeric materials.
2Duration of action of moving object
If biomolecules are administered frequently to maintain therapeutic effect, then treatment efficacy is improved, but cost, inconvenience, and risk of adverse reactions increase
Solution Approach 1:
The patent employs polymer conjugates that act as temporary, disposable extensions to biomolecule half-life. The polymer carrier is designed to be gradually cleared from the body, releasing the active biomolecule over an extended period. This approach replaces the need for frequent re-administration with a single or reduced number of doses, thereby reducing cumulative adverse reactions while maintaining therapeutic efficacy.
3Duration of action of stationary object
If polymers are attached to biomolecules to extend half-life, then circulating duration is improved, but manufacturing complexity increases
Solution Approach 1:
The patent utilizes self-service principles through site-specific conjugation methods where the biomolecule itself participates in the attachment process. For example, native or engineered functional groups on the biomolecule (such as N-terminal amines, C-terminal carboxyls, or specific amino acid side chains) serve as built-in attachment points for polymer conjugation. This eliminates the need for complex external coupling chemistry and simplifies manufacturing by allowing the biomolecule to direct its own modification.
4Manufacturing precision
If site-specific polymer conjugation is performed at N-terminus or C-terminus, then conjugation control is improved, but process complexity increases
Solution Approach 1:
The patent applies local quality by confining polymer conjugation to specific terminal regions (N-terminus or C-terminus) of the biomolecule rather than random attachment throughout the structure. This site-specific approach ensures uniform conjugation stoichiometry (typically one polymer per biomolecule) and maintains the biological activity of the biomolecule. The terminal regions are chosen because they are accessible, have unique chemical functionality, and do not interfere with critical functional domains of the biomolecule.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The conjugation process increases the in vivo half-life of biomolecules by at least 50%, improves stability, solubility, and reduces immunogenicity, leading to enhanced pharmacokinetics and targeted delivery.
Implementation Method 1
contacting the polypeptides with an initiator agent under conditions that permit attachment of the initiator agent to at least one of the N-terminus and the C-terminus
Implementation Method 2
incubated with a monomer under conditions that permit polymerization to occur from the initiator agent to form polypeptide-polymer conjugates
Data Source
AI summary
Methods for producing biomolecule-polymer conjugates, such as polypeptide-polymer conjugates, include attachment of an initiator agent to a biomolecule and in situ polymerization of a polymer from defined sites on the biomolecule. The conjugates may have desirable pharmacological properties and may be used therapeutically.